| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |